Journal article

Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas


Authors listFoja, S; Goldberg, M; Schagdarsurengin, U; Dammann, R; Tannapfel, A; Ballhausen, WG

Publication year2005

Pages1202-1208

JournalLiver International

Volume number25

Issue number6

ISSN1478-3223

eISSN1478-3231

DOI Linkhttps://doi.org/10.1111/j.1478-3231.2005.01174.x

PublisherWiley


Abstract
Aims: About 10-30% of primary liver cancers represent intrahepatic cholangiocarcinomas (IHCC). Since chromosomal losses of 3p are detectable in about 40% of cholangiocarcinomas our study aimed at the identification of mechanisms leading to functional deletion of tumor suppressor genes in this region. Our efforts focussed on genomic losses and epigenetic inactivation of two tumor suppressor genes, the fragile histidine triad (FHIT) and the ras association domain family 1 (RASSF1A) genes, both located on the short arm of chromosome 3. Methods: Methylation-specific PCR (MSP) and combined bisulfite-dependent restriction analysis (COBRA) were applied to detect epigenetic silencing of gene promoters. Genomic duplex PCR was used to identify exon losses of the FHIT gene. Nineteen paraffin-embedded samples of intrahepatic cholangiocarcinomas were studied. Results: Here we report for the first time that in addition to frequent losses of the exons 5 and 6, hypermethylation of the FHIT promoter occured in a significant portion of IHCC. Methylation specific PCR (MSP) detected epigenetic inactivation of the FHIT/FRA3B locus in 8 of 19 (42%) cases. Combined bisulfite restriction analysis (COBRA) revealed that high levels of methylated FHIT promoter sequences were present in 6 of the 8 methylation positive samples. In agreement with previous reports MSP identified hypermethylation of the RASSF1A gene in 13 of 19 (68%) IHCC specimens examined. Conclusions: Epigenetic silencing of the FHIT tumor suppressor gene is a novel inactivation mechanism to be considered in the development of intrahepatic cholangiocarcinomas. However, a statistically significant inverse correlation between K-Ras activation and RASSF1A inactivation was not found.



Citation Styles

Harvard Citation styleFoja, S., Goldberg, M., Schagdarsurengin, U., Dammann, R., Tannapfel, A. and Ballhausen, W. (2005) Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas, Liver International, 25(6), pp. 1202-1208. https://doi.org/10.1111/j.1478-3231.2005.01174.x

APA Citation styleFoja, S., Goldberg, M., Schagdarsurengin, U., Dammann, R., Tannapfel, A., & Ballhausen, W. (2005). Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas. Liver International. 25(6), 1202-1208. https://doi.org/10.1111/j.1478-3231.2005.01174.x


Last updated on 2025-21-05 at 15:35